The Evolution and Management of Migraine Recurrence Beyond 24 Hours

Completed

• Conditions: Migraine

• Registration Number: NCT00754611
• Lead Sponsor: Rowan University

Brief Summary

What is the course of migraine headache recurrence, how is it managed, what characteristics are associated with it, and how does it influence patient satisfaction with treatment?

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2008-09-09
• Study First Submitted QC: 2008-09-16
• Study First Posted: 2008-09-18
• Study Start: 2008-12
• Primary Completion: 2010-12
• Study Completion: 2010-12
• Status Verified: 2019-10
• Last Update Submitted: 2019-10-24
• Last Update Posted: 2019-10-28

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 100

Inclusion Criteria

• Female and male patients at University Headache Center with > 6 month diagnosis of migraine with and/or without aura (ICHD-II)
• Greater than or equal to 18 years old

Exclusion Criteria

• Greater than 15 days/month total headache days
• Analgesic use greater than 15 days/month (other than aspirin less than or equal to 325mg/d)

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Primary efficacy outcomes will be sustained pain free response between 4 and 72 hours after initial abortive medication dosing (lack of recurrence over 72 hours)	4 to 72 hours

Secondary Outcome Measures

Name	Time	Method
Rate of recurrence among multiple attacks per subject	72 hours
Pain response and pain free data	30 minutes, 1,2,4,24,48,and 72 hours
Rate of recurrence, time of recurrence, time to re-dosing	72 hours

Trial Locations

Locations (1)

University of Medicine and Dentistry of New Jersey; 🇺🇸 Stratford, New Jersey, United States